Cadrenal Therapeutics, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Cadrenal Therapeutics, Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Cadrenal Therapeutics, Inc. made a loss over the last year. Cadrenal Therapeutics, Inc. owes $0.27 for every $1 it owns. Cadrenal Therapeutics, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossCadrenal Therapeutics, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.84The share price is 0.84 times Cadrenal Therapeutics, Inc.'s book value per share, lower than 82% of Healthcare companies in United States.
Market cap
$3 MThe total market value of all of Cadrenal Therapeutics, Inc.'s shares at today's price (share price × number of shares), smaller than 95% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$4 MWhat Cadrenal Therapeutics, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.15Net worth divided by the number of shares. The share price of $0.96 is 0.8 times this, which is the P/B above.
Return on equity (ROE)
-275.2%Cadrenal Therapeutics, Inc. lost 275.2% of its shareholders' money over the last year, lower than 88% of Healthcare companies in United States.
Owes vs Owns
0.27×Cadrenal Therapeutics, Inc. owes $0.27 for every $1 it owns (low), lower than 64% of Healthcare companies in United States.
Dividend yield
NoneCadrenal Therapeutics, Inc. does not currently pay a dividend.
Profit growth
LossCadrenal Therapeutics, Inc. made a loss in each of the last two years.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Cadrenal Therapeutics, Inc.: $3 M ÷ $4 M (30 Jun 2026) = 0.8.
What is Cadrenal Therapeutics, Inc.'s return on equity?
Cadrenal Therapeutics, Inc. lost 275.2% of its shareholders' money over the last year, lower than 88% of Healthcare companies in United States.
How much does Cadrenal Therapeutics, Inc. owe compared with what it owns?
Cadrenal Therapeutics, Inc. owes $0.27 for every $1 it owns (low), lower than 64% of Healthcare companies in United States.
Does Cadrenal Therapeutics, Inc. pay a dividend?
No. Cadrenal Therapeutics, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.